1. Home
  2. LAW vs TSHA Comparison

LAW vs TSHA Comparison

Compare LAW & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CS Disco Inc.

LAW

CS Disco Inc.

HOLD

Current Price

$7.26

Market Cap

466.2M

Sector

Technology

ML Signal

HOLD

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

HOLD

Current Price

$5.25

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAW
TSHA
Founded
2013
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
466.2M
1.5B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
LAW
TSHA
Price
$7.26
$5.25
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$7.75
$10.22
AVG Volume (30 Days)
207.9K
3.5M
Earning Date
02-19-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$152,677,000.00
$6,310,000.00
Revenue This Year
$8.51
N/A
Revenue Next Year
$8.39
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.33
N/A
52 Week Low
$3.31
$1.05
52 Week High
$9.11
$6.02

Technical Indicators

Market Signals
Indicator
LAW
TSHA
Relative Strength Index (RSI) 38.45 48.63
Support Level $7.73 $5.58
Resistance Level $8.33 $6.02
Average True Range (ATR) 0.29 0.26
MACD -0.16 -0.07
Stochastic Oscillator 2.57 9.88

Price Performance

Historical Comparison
LAW
TSHA

About LAW CS Disco Inc.

CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

Share on Social Networks: